Log in to save to my catalogue

Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accel...

Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9470884

Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model

About this item

Full title

Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model

Publisher

England: John Wiley & Sons, Inc

Journal title

Aging cell, 2022-09, Vol.21 (9), p.e13683-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

DNA damage is a causative factor in ageing of the vasculature and other organs. One of the most important vascular ageing features is reduced nitric oxide (NO)soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signaling. We hypothesized that the restoration of NO‐sGC‐cGMP signaling with an sGC activator (BAY 54–6544) may have ben...

Alternative Titles

Full title

Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9470884

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9470884

Other Identifiers

ISSN

1474-9718,1474-9726

E-ISSN

1474-9726

DOI

10.1111/acel.13683

How to access this item